June 19, 2017

Testing will be available at more than 220 participating Walgreens stores in 130 cities.

June 13, 2017
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). 
June 12, 2017

The latest report on generics cost savings, compiled by the QuintilesIMS Institute on behalf of the Association for Accessible Medicines, highlights the key role generics play in healthcare cost savings. 

June 9, 2017

Jeff Park was OptumRx’s COO from July 2015 to July 2016 following the company’s merger with Catamaran, where Park had been EVP operations since March 2014.

June 9, 2017

According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.

June 6, 2017

The Cincinnati Enquirer included Diplomat Specialty Infusion Group as one of its Top Workplaces 2017. 

June 1, 2017

Since 2011, 68 novel therapies have been approved globally across 22 cancer indications. The QunitilesIMS Institute report looks at what technological advances and development trends have made this possible, as well as their cost.

May 31, 2017

Under the acquisition, MedCart will continue to operate as it did before, but as a new business unit under Albertsons’ pharmacy team structure, with the leadership team reporting directly to Albertsons group VP pharmacy operations, Dain Rusik.

May 30, 2017
India-based Cipla announced May 25 that it would be cutting its investment in its biosimilars development arm to focus on respiratory products, Reuters reported. The company has halted plans to invest $1.3 billion in building a biotechnology plant in South Africa and is on the lookout to partner with other companies on its already existing biosimilars efforts, the report said. "We are not moving away from biosimilars. However, we are not in the aim to make them at $1 a day,” Cipla CEO Umang Vohra said. (Reuters)
May 26, 2017

 Diplomat Pharmacy will be dispensing a recently approved treatment for rheumatoid arthritis.

May 25, 2017

Asembia’s Asembia1 specialty pharmacy workflow platform will be integrated with QS/1’s software platform as a result of the partnership.

May 24, 2017

“We want to be more impactful to the people we serve and continue to build up our portfolio of products,” Larry Merlo said during the UBS Healthcare Conference in New York City.

May 24, 2017

Government agency accepted Biologics License Application to extend Opdivo’s use to patients with hepatocellular carcinoma after prior sorafenib therapy.

May 24, 2017

Under the law, which was signed by President Barack Obama in December 2016, the payment structure for infusion drugs under Medicare Part B changed from an average wholesale price to an average sales price.

May 23, 2017

According to the agency, this is the first time it has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.

May 23, 2017

“Pharmacists need to understand what’s happening around them regarding the availability of precision medicines and their profiles,” Murray Aitken, executive director of the Quintiles IMS Institute and co-author of the report, said during the International Pharmaceutical Federation 6th Pharmaceutical Sciences World Congress.

May 22, 2017

Hoffman La Roche’s drug takes aim at the form of vasculitis, a group of disorders that results in inflammation of blood vessels.

May 19, 2017

The oral therapy is administered twice daily for adults with an FLT3 mutation-positive acute myeloid leukemia diagnosis.

May 17, 2017

The company’s doxorubicin hydrochloride liposome injection is a sterile, translucent, red liposomal dispersion in 10-mL or 30-mL glass, single-dose vials.

May 17, 2017

According to the FDA, the expanded approval of Kalydeco triples the number of rare gene mutations that the drug can now treat, expanding the indication from the treatment of 10 mutations, to 33.

May 17, 2017

During an analyst meeting, the company also said it will share its plans to continue driving sustainable growth by leveraging its strong portfolio of core blockbuster products, the “industry-leading” productivity of its innovation model, and the pending acquisition of Swiss-based biotech company Actelion.

May 17, 2017

Cliff Osbon talks about how the independent specialty pharmacy differentiates itself from the competition so much that was named to Inc. Magazine’s top growth list five times. 

May 16, 2017

SB-525 uses a recombinant adeno-associated virus to deliver a human Factor VIII cDNA construct and proprietary, synthetic liver-specific promoter to the nucleus of liver cells with a single infusion.

May 16, 2017

Clofarabine injection is a purine nucleoside metabolic inhibitor indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.